Sign in
Taking people in United StatesPhase 2

Tests azithromycin to lower cesarean birth during labor induction in obese first-time mothers

Tests an antibiotic given during labor induction in first-time mothers with obesity near term.

Key facts

Who runs it
University of Oklahoma
Where
Oklahoma City, United StatesSee the site
Trial code
Registry title
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
Status
Recruiting
Phase
Phase 2
People taking part
787 people, planned
Started
29 Apr 2025
Expected to end
Dec 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Azithromycin
  • Placebo
Record updated
12 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women with obesity who are having their first baby at term and are having labor induced. It tests whether antibiotics during labor lower the cesarean rate.

Age
15 to 45 years
Sex
Women only
Disease stage
BMI of 30 or more; no earlier delivery at or beyond 20 weeks of pregnancy; labor is being induced; pregnancy is 37 weeks or more
Earlier treatment
Not receiving antibiotics for group B strep (GBS) prevention during labor

Main reasons for not taking part

  • Baby died before labor induction
  • Known fetal anomaly
  • Multiple gestation
  • Ruptured membranes for more than 12 hours
  • Allergy to azithromycin or beta-lactam antibiotics

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • BMI ≥30
  • No prior deliveries at or beyond 20 weeks gestation
  • Undergoing induction of labor
  • Gestational age 37 weeks or more
  • Age 15-45
  • Not receiving IAP for GBS prophylaxis

Who cannot take part

  • Fetal death prior to labor induction
  • Previous myometrial surgery
  • Chorioamnionitis or other infection requiring antibiotics at the start of the labor induction
  • Allergy to azithromycin or beta-lactam antibiotics
  • Known fetal anomaly
  • Multiple gestation
  • Ruptured membranes for more than 12 hours

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 15 and 45 years old?

Where in United States

  • University of Oklahoma Health Sciences CenterOklahoma City, United StatesContact: Christy Zornes, MHRTaking people

About the trial

What the trial wants to find out

Obesity increases the risk of pregnancy complications, including puerperal infections and cesarean delivery, and risk rises with increasing body mass index (BMI). Since obese women are more likely to have comorbidities that would necessitate delivery prior to their due date (i.e. prior to 40 weeks gestation), and class III obesity specifically is an indication for delivery by 39 weeks, these patients have a high rate of labor induction. In nulliparous women from the general population (obese and non-obese), labor induction at 39 weeks (compared to expectant management) is associated with less maternal morbidity and a lower cesarean rate. Researchers previously conducted a pilot randomized placebo-controlled trial in obese, nulliparous women undergoing labor induction at term and found that the cesarean delivery rate was lower in women who received a prophylactic antibiotic regimen during labor compared with those who received the placebo. Researchers proposed multi-center trial aims to test this hypothesis in a large sample with adequate power to determine whether prophylactic antibiotics during labor are associated with a decrease in the rate of cesarean delivery in term, nulliparous, obese women. If the findings from the pilot trial are confirmed, this would represent a novel intervention to decrease the cesarean delivery rate in a subset of women at highest risk for cesarean-related complications.

The 2 groups in the trial

  • Prophylactic antibioticsExisting treatment, for comparison

    Azithromycin 500 milligrams intravenously once and cefazolin 2 grams intravenously every 8 hours for up to three doses

    Treatment: Azithromycin

  • PlaceboPlacebo, for comparison

    Placebos, similar in appearance, in place of azithromycin and cefazolin

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0 (APPOINT 2.0): A Multi-center Randomized Controlled Trial
Plain-language title
Tests azithromycin to lower cesarean birth during labor induction in obese first-time mothersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06488781, who can take part
Record updated
12 March 2026